{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"23.800","floor":"20.000"},"ipodate":{"start":"2020-10-22 00:00:00","end":"2020-10-28 00:00:00"},"minimumcapital":"12019.92","subscribed":"449.42","marketcap":"89.53億","H_marketcap":"--","pe":"--","codesrate":"5.00","link":"https://staticpdf.iqdii.com/stockdata/notice/02126/2020/2020102200036_c.pdf","ipopricing":"23.800","resultdate":"2020-11-02 00:00:00","enddate":"2020-10-28 00:00:00","listeddate":"2020-11-03 00:00:00","issuenumber":"9769.20萬","issuenumberhK":"4884.60萬","issuenumberother":"4884.60萬","grayprice":"24.40","sponsors":"高盛(亞洲)有限責任公司,瑞銀證券香港有限公司","raisemoney":"219670.00萬","use":"1、約878.7百萬港元（占所得款項凈額約40.0%）預期將用于我們的核心候選產品relma-cel；\n2、約746.9百萬港元（占所得款項凈額的34.0%）預期將用于其他侯選產品；\n3、約351.5百萬港元（占所得款項凈額的16.0%）預期將用于潛在管線產品；\n4、約219.7百萬港元（占所得款項凈額的10.0%）預期將用于營運資金及一般公司用途。","shares":500,"leadagent":"高盛(亞洲)有限責任公司,瑞士銀行香港分行,中國國際金融香港證券有限公司,中信里昂證券有限公司,工銀國際證券有限公司,浦銀國際融資有限公司,未來資產證券(香港)有限公司,中銀國際亞洲有限公司","bookrunners":"高盛(亞洲)有限責任公司,瑞士銀行香港分行,中國國際金融香港證券有限公司,中信里昂證券有限公司,工銀國際融資有限公司,浦銀國際融資有限公司,未來資產證券(香港)有限公司,中銀國際亞洲有限公司","coordinator":"高盛(亞洲)有限責任公司,瑞士銀行香港分行,中國國際金融香港證券有限公司,中信里昂證券有限公司","firstDayOpen":"24.35","IsEiio":0,"Interestdays":5,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"高盛(亞洲)有限責任公司","code":"E02126","name":"藥明巨諾－Ｂ","fullname":"藥明巨諾(開曼)有限公司"},"institutioninfo":{"principaloffice":"中國上海自由貿易試驗區美盛路225號42號樓4樓","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"李怡平","secretary":"梁雪穎","telephone":"(8621) 5046 4201","substantialshareholders":"Juno(18.67%),Syracuse Cayman(11.53%),WXAT HK(10.16%),Temasek(6.03%)","principalactivities":"公司是中國領先的臨床及臨床前階段細胞治療公司。","website":"http://www.jwtherapeutics.com/"},"managerinfo":[{"managername":"李怡平","post":"主席、首席執行官兼執行董事","rankno":1},{"managername":"Hans Edgar Bishop","post":"非執行董事","rankno":2},{"managername":"Krishnan Viswanadhan","post":"非執行董事","rankno":3}],"investorinfo":[{"institutionname":"Oaktree Funds","shareholding":"6,512,500.0","percentage":6.67,"ReleaseDate":"2021-05-03 00:00:00","relatedparty":"Oaktree Capital Management, L.P.","subsidiary":["Oaktree Funds"],"InverstorType":"基金"},{"institutionname":"Platinum Investment Management Limited","shareholding":"6,512,500.0","percentage":6.67,"ReleaseDate":"2021-05-03 00:00:00","relatedparty":"","subsidiary":[],"InverstorType":"公司"},{"institutionname":"Rock Springs Capital Master Fund LP","shareholding":"6,512,500.0","percentage":6.67,"ReleaseDate":"2021-05-03 00:00:00","relatedparty":"Rock Springs Capital Management LP","subsidiary":["Rock Springs Capital Master Fund LP"],"InverstorType":"基金"},{"institutionname":"RWC Asset Advisors (US) LLC","shareholding":"6,512,500.0","percentage":6.67,"ReleaseDate":"2021-05-03 00:00:00","relatedparty":"","subsidiary":[],"InverstorType":"公司"}],"TotalShareholdingPercentage":50.01},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":8}